⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10004661 | 0.97 | TSHR (0.71) | — | |
| SCHEMBL6575728 | 0.97 | TSHR (0.71) | — | |
| SCHEMBL4609065 | 0.97 | TSHR (0.71) | — | |
| SCHEMBL434540 | 0.97 | TSHR (0.71) | — | |
| SCHEMBL7221658 | 0.97 | TSHR (0.71) | — | |
| SCHEMBL1706463 | 0.97 | — | — | |
| SCHEMBL9096720 | 0.97 | TSHR (0.71) | — | |
| SCHEMBL8864033 | 0.97 | TSHR (0.71) | — | |
| SCHEMBL8864071 | 0.97 | TSHR (0.71) | — | |
| SCHEMBL3408123 | 0.97 | TSHR (0.71) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119639413-A | Perovskite quantum dot glue and preparation method and application thereof | 极电光能有限公司 | 2025-03-18 | — | — | CN | claimed |
| JP-8298134-A | — | — | None | — | — | JP | disclosed |
| US-12617747-B2 | Cannabinoid analogs and methods for their preparation | INMED PHARMACEUTICALS INC. (CA) | 2026-05-05 | — | — | US | disclosed |
| US-20260001914-A1 | MACROCYCLIC PEPTIDES TARGETING KRAS | MERCK SHARP & DOHME LLC (US) | 2026-01-01 | — | — | US | disclosed |
| CN-119639413-A | Perovskite quantum dot glue and preparation method and application thereof | 极电光能有限公司 | 2025-03-18 | — | — | CN | disclosed |
| WO-2024198046-A1 | BIOMARKER AND SYSTEM FOR PREDICTING EVOLUTION INTO ACLF OR DEATH OF ACLF PATIENT, AND USES THEREOF | 上海甘宁医疗科技有限公司 | 2024-10-03 | — | — | WO | disclosed |
| CN-118256514-A | AXMI669 and AXMI991 toxin genes and methods of use thereof | 巴斯夫农业种子解决方案美国有限责任公司 | 2024-06-28 | — | — | CN | disclosed |
| WO-2024117205-A1 | BICYCLIC PYRIDINE DERIVATIVE AND SALT THEREOF, AND HARMFUL ORGANISM CONTROL AGENT CHARACTERIZED BY CONTAINING SAID DERIVATIVE OR SALT THEREOF AS ACTIVE INGREDIENT | 北興化学工業株式会社 | 2024-06-06 | — | — | WO | disclosed |
| CN-110267975-B | AXMI669 and AXMI991 toxin genes and methods of use thereof | 巴斯夫农业种子解决方案美国有限责任公司 | 2024-04-19 | — | — | CN | disclosed |
| US-20240117388-A1 | ACYL ACTIVATING ENZYMES FOR PREPARATION OF CANNABINOIDS | BAYMEDICA, INC. | 2024-04-11 | — | — | US | disclosed |
| WO-1998011129-A1 | C-TERMINAL MODIFIED (N-SUBSTITUTED)-2-INDOLYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES | IDUN PHARMACEUTICALS, INCORPORATED (US) | 1998-03-19 | — | — | WO | disclosed |
| WO-1998005649-A1 | SUBSTITUTED 3-PHENYL PYRAZOLES | BASF AKTIENGESELLSCHAFT (DE) | 1998-02-12 | — | — | WO | disclosed |
| WO-1998003661-A2 | ANTIMICROBIAL AGENTS, DIAGNOSTIC REAGENTS, AND VACCINES BASED ON UNIQUE APICOMPLEXAN PARASITE COMPONENTS | ARCH DEVELOPMENT CORPORATION (US) | 1998-01-29 | — | — | WO | disclosed |
| WO-1997035845-A1 | SUBSTITUTED 1-METHYL-3-BENZYLURACILS | BASF AKTIENGESELLSCHAFT (DE) | 1997-10-02 | — | — | WO | disclosed |
| WO-1997030059-A1 | SUBSTITUTED 2-PHENYLPYRIDINES | BASF AKTIENGESELLSCHAFT (DE) | 1997-08-21 | — | — | WO | disclosed |
| WO-1997030060-A1 | SUBSTITUTED AROMATIC PHOSPHONIC ACID DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 1997-08-21 | — | — | WO | disclosed |
| WO-1997001543-A1 | 1-AMINO-3-BENZYLURACILS | BASF AKTIENGESELLSCHAFT (DE) | 1997-01-16 | — | — | WO | disclosed |
| JP-H08298134-A | NONAQUEOUS ELECTROLYTE | SONY CORP | 1996-11-12 | — | — | JP | disclosed |
| EP-0673911-A1 | Process for producing optically active carboxylic acids and chiral ligands for this purpose | Takasago International Corporation (JP) | 1995-09-27 | — | — | EP | disclosed |
| US-5244597-A | Liquid crystalline mixtures having a chiral tilted smectic phase | HOFFMANN-LA ROCHE INC. (US) | 1993-09-14 | — | — | US | disclosed |